Farther Finance Advisors’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.16K Buy
1,044
+903
+640% +$2.7K ﹤0.01% 5004
2026
Q1
$440 Buy
141
+68
+93% +$289 ﹤0.01% 5297
2025
Q4
$264 Hold
73
﹤0.01% 5163
2025
Q3
$275 Buy
73
+54
+284% +$208 ﹤0.01% 4657
2025
Q2
$74 Hold
19
﹤0.01% 4339
2025
Q1
$90 Hold
19
﹤0.01% 4077
2024
Q4
$137 Hold
19
﹤0.01% 3731
2024
Q3
$117 Hold
19
﹤0.01% 3754
2024
Q2
$137 Sell
19
-77
-80% -$568 ﹤0.01% 3554
2024
Q1
$982 Buy
96
+77
+405% +$783 ﹤0.01% 2781
2023
Q4
$214 Buy
+19
New +$79 ﹤0.01% 3214

Other funds holding ALT

Farther Finance Advisors's ALT Position: Q2 2026 in Review

Farther Finance Advisors increased its Altimmune (ALT) stake by 640% in Q2 2026, buying an estimated $2.7K and bringing the position to 1,044 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #5004.

Farther Finance Advisors first reported a position in ALT in Q4 2023 and has held it in 11 quarters since. 38 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Farther Finance Advisors held 1,044 shares of Altimmune worth $3.16K as of Q2 2026.
  • Farther Finance Advisors bought 903 Altimmune shares in Q2 2026, an estimated $2.7K.
  • Altimmune made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5004 holding.
  • Farther Finance Advisors first reported a position in Altimmune in Q4 2023 and has held it in 11 quarters since.
  • 38 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.